Search Videos and More
News
Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients
In a recent study, Fox Chase Cancer Center researchers sought to identify predictors of concern in men who recently underwent treatment for prostate cancer.
News
Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery
Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.
News
International Collaborations Help Optimize Partial Nephrectomy Techniques
The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.
Video
Retroperitoneoscopic Robot-Assisted Partial Nephrectomy on Morbidly Obese Patient with Tumor in the Upper Pole
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.
News
De-escalating Treatment for Bladder and Prostate Cancers
Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. Here are some lessons Fox Chase Cancer Center researchers are learning about these de-escalation approaches.
News
SpaceOAR Hydrogel Reduces Side Effects of Prostate Cancer Radiation Therapy
In a minimally invasive outpatient procedure, the two liquid components of SpaceOAR hydrogel are injected through the peritoneum (transperineally) into the space between the rectal wall and the prostate by a urologist. The procedure is done under anesthesia with ultrasound guidance.